Shared Causal Paths underlying Alzheimer's dementia and Type 2 Diabetes

被引:45
作者
Hu, Zixin [1 ,2 ,4 ]
Jiao, Rong [3 ]
Wang, Panpan [1 ,2 ]
Zhu, Yun [5 ]
Zhao, Jinying [5 ]
De Jager, Phil [6 ]
Bennett, David A. [7 ]
Jin, Li [1 ,2 ,4 ]
Xiong, Momiao [3 ]
机构
[1] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai, Peoples R China
[2] Fudan Univ, Sch Life Sci, Innovat Ctr Genet & Dev, Shanghai, Peoples R China
[3] Univ Texas Hlth Sci Ctr Houston, Sch Publ Hlth, Dept Biostat & Data Sci, Houston, TX 77030 USA
[4] Fudan Univ, Human Phenome Inst, Shanghai, Peoples R China
[5] Univ Florida, Dept Epidemiol, Gainesville, FL 32611 USA
[6] Columbia Univ, Ctr Translat & Computat Neuroimmunol, Dept Neurol, Med Ctr, New York, NY 10033 USA
[7] Rush Univ, Rush Alzheimers Dis Ctr, Med Ctr, Chicago, IL 60612 USA
关键词
DNA METHYLATION; TRANSCRIPTION FACTOR; DISEASE; MELLITUS; BRAIN; APOPTOSIS; PATHOLOGY; PATHWAYS; MEMORY; GENES;
D O I
10.1038/s41598-020-60682-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Although Alzheimer's disease (AD) is a central nervous system disease and type 2 diabetes MELLITUS (T2DM) is a metabolic disorder, an increasing number of genetic epidemiological studies show clear link between AD and T2DM. The current approach to uncovering the shared pathways between AD and T2DM involves association analysis; however such analyses lack power to discover the mechanisms of the diseases. As an alternative, we developed novel causal inference methods for genetic studies of AD and T2DM and pipelines for systematic multi-omic casual analysis to infer multilevel omics causal networks for the discovery of common paths from genetic variants to AD and T2DM. The proposed pipelines were applied to 448 individuals from the ROSMAP Project. We identified 13 shared causal genes, 16 shared causal pathways between AD and T2DM, and 754 gene expression and 101 gene methylation nodes that were connected to both AD and T2DM in multi-omics causal networks.
引用
收藏
页数:15
相关论文
共 72 条
[1]   Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? [J].
Akter, Kawser ;
Lanza, Emily A. ;
Martin, Stephen A. ;
Myronyuk, Natalie ;
Rua, Melanie ;
Raffa, Robert B. .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (03) :365-376
[2]  
[Anonymous], FRONTIERS AGING NEUR
[3]   Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function [J].
Arvanitakis, Z ;
Wilson, RS ;
Bienias, JL ;
Evans, DA ;
Bennett, DA .
ARCHIVES OF NEUROLOGY, 2004, 61 (05) :661-666
[4]   Diabetes is related to cerebral infarction but not to AD pathology in older persons [J].
Arvanitakis, Z. ;
Schneider, J. A. ;
Wilson, R. S. ;
Li, Y. ;
Arnold, S. E. ;
Wang, Z. ;
Bennett, D. A. .
NEUROLOGY, 2006, 67 (11) :1960-1965
[5]   Diabetes and Alzheimer's disease crosstalk [J].
Baglietto-Vargas, David ;
Shi, Jessica ;
Yaeger, Devin M. ;
Ager, Rahasson ;
LaFerla, Frank M. .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2016, 64 :272-287
[6]  
Bennett DA, 2012, CURR ALZHEIMER RES, V9, P646
[7]  
Bennett DA, 2012, CURR ALZHEIMER RES, V9, P628
[8]   The Down syndrome critical region protein TTC3 inhibits neuronal differentiation via RhoA and citron kinase [J].
Berto, Gaia ;
Camera, Paola ;
Fusco, Carlo ;
Imarisio, Sara ;
Ambrogio, Chiara ;
Chiarle, Roberto ;
Silengo, Lorenzo ;
Di Cunto, Ferdinando .
JOURNAL OF CELL SCIENCE, 2007, 120 (11) :1859-1867
[9]  
Bouchouirab F.-Z, 2018, CANADIAN J DIABETES, V42
[10]   Distributed optimization and statistical learning via the alternating direction method of multipliers [J].
Boyd S. ;
Parikh N. ;
Chu E. ;
Peleato B. ;
Eckstein J. .
Foundations and Trends in Machine Learning, 2010, 3 (01) :1-122